Citation Impact
Citing Papers
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Cochrane Database of Systematic Reviews
2003 Standout
Antibiotic resistance and CYP2C19 polymorphisms affect the efficacy of concomitant therapies forHelicobacter pyloriinfection: an open-label, randomized, single-centre clinical trial
2016
The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults
2016
Bowel Disorders
2016 Standout
Effects of anti-Helicobacter pylori concomitant therapy and probiotic supplementation on the throat and gut microbiota in humans
2017
Cystic fibrosis
2016 Standout
Attempts to enhance the eradication rate ofHelicobacter pyloriinfection
2014
Probiotics inHelicobacter pylorieradication therapy: A systematic review and meta-analysis
2015
Exocrine pancreatic cancer: Symptoms at presentation and their relation to tumour site and stage
2005
Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy
2016
The Oklahoma thrombotic thrombocytopenic Purpura-Hemolytic uremic syndrome (TTP-HUS) registry: a community perspective of patients with clinically diagnosed TTP-HUS
2004
Modulating bile acid pathways and TGR5 receptors for treating liver and GI diseases
2017
Effects of Gender and Age at Diagnosis on Disease Progression in Long-term Survivors of Cystic Fibrosis
2010
Diagnosis and management of cricopharyngeal achalasia and other upper esophageal sphincter opening disorders
2000
ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease
2013 Standout
Pancreatic Adenocarcinoma
2014 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Randomized Clinical Trial: Esomeprazole, Bismuth, Levofloxacin, and Amoxicillin or Cefuroxime as First-Line Eradication Regimens for Helicobacter pylori Infection
2017
European Cystic Fibrosis Society Standards of Care: Best Practice guidelines
2014
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
2018 Standout
Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area
2016
Diagnosis of Celiac Disease
2012
Gastric cancer
2020 Standout
A review of rescue regimens after clarithromycin-containing triple therapy failure (forHelicobacter pylorieradication)
2013
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection
2017
The pros, cons, and many unknowns of probiotics
2019 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Different antibiotic susceptibility between antrum and corpus of the stomach, a possible reason for treatment failure ofHelicobacter pyloriinfection
2014
Systematic review with meta‐analysis: Saccharomyces boulardii supplementation and eradication of Helicobacter pylori infection
2015
Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication of Helicobacter pylori
2014
Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States
2017 Standout
Antimicrobial Susceptibility‐Guided Therapy Versus Empirical Concomitant Therapy for Eradication of Helicobacter pylori in a Region with High Rate of Clarithromycin Resistance
2015
Works of Inés Modolell being referenced
Vagaries of clinical presentation of pancreatic and biliary tract cancer
1999
Fourth‐line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures
2012
Helicobacter Pylori First-Line and Rescue Treatments in the Presence of Penicillin Allergy
2014
Gastrointestinal, Liver, and Pancreatic Involvement in Adult Patients with Cystic Fibrosis
2001
Are positive serum-IgA-tissue-transglutaminase antibodies enough to diagnose coeliac disease without a small bowel biopsy? Post-test probability of coeliac disease
2012
Third-Line Rescue Therapy with Bismuth-Containing Quadruple Regimen After Failure of Two Treatments (with Clarithromycin and Levofloxacin) for H. pylori Infection
2013
Acute pancreatitis as a triggering factor for thrombotic thrombocytopenic purpura
1998
Second-line Therapy With Levofloxacin After Failure of Treatment to Eradicate Helicobacter pylori Infection
2012
Pharyngo-Esophageal Motility Disturbances in Patients with Myotonic Dystrophy
1999
Optimised empiric triple and concomitant therapy forHelicobacter pylorieradication in clinical practice: the OPTRICON study
2015
Randomised clinical trial: colestyramine vs. hydroxypropyl cellulose in patients with functional chronic watery diarrhoea
2015